What one share of ClearPoint Neuro holds
We are a commercial-stage medical device company, incorporated in 1998 as a Delaware corporation, that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain.
ClearPoint Neuro’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.45 |
|---|---|
| Profit | −$1.18 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | −$1.07 |
| Cash and investments | $0.96 |
| Debt | $1.65 |
| Book value | $0.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $15.76 | −$55.83 | $0.36 | −$45.88 | — | −$90.57 |
| 2011 | $9.57 | −$20.83 | $0.07 | −$15.70 | — | −$54.32 |
| 2012 | $5.01 | −$5.82 | $0.13 | −$7.49 | — | −$6.54 |
| 2013 | $2.75 | −$4.80 | $0.05 | −$5.49 | — | −$4.67 |
| 2014 | $2.43 | −$3.20 | $0.03 | −$4.93 | — | −$0.05 |
| 2015 | $2.44 | −$4.48 | $0.04 | −$4.62 | — | −$0.87 |
| 2016 | $2.09 | −$2.93 | $0.04 | −$2.15 | — | −$0.21 |
| 2017 | $0.95 | −$0.93 | $0.00 | −$0.78 | — | $0.55 |
| 2018 | $0.67 | −$0.56 | $0.01 | −$0.43 | — | $0.14 |
| 2019 | $0.85 | −$0.42 | — | — | — | $0.30 |
| 2020 | $0.81 | −$0.43 | $0.00 | −$0.50 | — | $0.14 |
| 2021 | $0.79 | −$0.69 | $0.01 | −$0.62 | — | $2.06 |
| 2022 | $0.85 | −$0.68 | $0.01 | −$0.68 | — | $1.50 |
| 2023 | $0.97 | −$0.90 | $0.03 | −$0.59 | — | $0.86 |
| 2024 | $1.16 | −$0.70 | $0.01 | −$0.34 | — | $0.92 |
| 2025 | $1.31 | −$0.90 | $0.02 | −$0.86 | — | $0.95 |
Common questions about ClearPoint Neuro
How much does one share of ClearPoint Neuro earn?
Over the last 12 months, ClearPoint Neuro lost $1.18 for each share on $1.45 of sales.
Does ClearPoint Neuro pay a dividend?
ClearPoint Neuro didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is ClearPoint Neuro’s book value per share?
ClearPoint Neuro’s book value is $0.35 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of ClearPoint Neuro have?
Each share of ClearPoint Neuro has $0.96 of cash and investments and $1.65 of debt, as of June 30, 2026.
What is ClearPoint Neuro’s free cash flow per share?
−$1.07 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has ClearPoint Neuro bought back shares?
ClearPoint Neuro’s share count rose about 16621% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.